|
|
|
 |
Last Updated: Feb 6, 2011 - 4:55:42 PM |
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
Deficiency of the Dicer enzyme in retinal cells linked to age-related macular degeneration
A team of researchers, led by University of Kentucky ophthalmologist Dr. Jayakrishna Ambati, has discovered a molecular mechanism implicated in geographic atrophy, the major cause of untreatable blindness in the industrialized world.
Feb 6, 2011 - 4:45:23 PM
|
Latest Research
ONR's TechSolutions providing SEALs with new glasses that change lens color on the fly
ARLINGTON, Va. - The Office of Naval Research's (ONR) TechSolutions department is set to deliver to Navy Special Warfare Command personnel later this year new protective eyewear that will eliminate the need for warfighters to stop to change out colored lenses to accommodate differences in light levels.
Jan 27, 2011 - 5:00:00 AM
|
Latest Research
Case Western Reserve receives $10M to study retinal disease, develop new treatments
The Departments of Pharmacology and Ophthalmology and Visual Sciences at Case Western Reserve University School of Medicine have been awarded a $10.1 million grant from the National Eye Institute (NEI) to research and develop new treatments for diseases of the retina, a leading cause of blindness.
Dec 28, 2010 - 5:00:00 AM
|
Latest Research
Eye movement problems common cause of reading difficulties in stroke patients
Visual problems can affect up to two thirds of stroke patients, but can sometimes go undetected if patients do not recognise them as an after-effect of the condition or if they are unable to communicate the problem to their medical team or families.
Dec 1, 2010 - 5:00:00 AM
|
Latest Research
NIH adds first images to major research database
The National Institutes of Health has expanded a genetic and clinical research database to give researchers access to the first digital study images. The National Eye Institute (NEI), in collaboration with the National Center for Biotechnology Information (NCBI), has made available more than 72,000 lens photographs and fundus photographs of the back of the eye, collected from the participants of the Age-Related Eye Disease Study (AREDS).
Nov 23, 2010 - 5:00:00 AM
|
Latest Research
University at Buffalo symposium on in silico methods, high throughput screening
BUFFALO, N.Y. -- Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept. 11 on Twenty-first Century Bioscience: In Silico Methods and High-Throughput Screening, which will feature a variety of cutting-edge advances in the field developed by researchers in Western New York and throughout the US.
Sep 2, 2010 - 4:00:00 AM
|
Latest Research
Gravity-defying illusion wins international contest
A new amazing illusion proves that defying gravity may be as simple as your point of view.
May 18, 2010 - 4:00:00 AM
|
Latest Research
Mass. Eye and Ear receives NEI grant renewal for 'growing' clinical/scientists
Boston (May 10, 2010) - The Massachusetts Eye and Ear Infirmary, Harvard Medical School Department of Ophthalmology, has been awarded a grant renewal from the National Institutes of Health, National Eye Institute (NEI), to recruit, train and support first-rate clinician scientists to promote translational and clinical research into cures for eye disease.
May 10, 2010 - 4:00:00 AM
|
Latest Research
Strategy to help doctors determine when to treat retinopathy of prematurity
NEW YORK (April 29, 2010) -- Scientists have shown that through eye examinations, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children.
Apr 29, 2010 - 4:00:00 AM
|
Latest Research
:
Ophthalmology
First sign of injury in glaucoma occurs in the neuronal connections in the brain
In a recent study, David Calkins, Ph.D., director of Research at the VEI, discovered that the first sign of injury in glaucoma actually occurs in the brain.
Mar 1, 2010 - 1:08:56 PM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
Quit smoking to save your eyes
A UCLA study finds that even after age 80, smoking continues to increase one's risk for age-related macular degeneration (AMD), the leading cause of blindness in Americans over 65.
Jan 1, 2010 - 11:09:08 AM
|
Latest Research
New effort to battle antibiotic resistance rallies researchers throughout Harvard University
Boston. MA--The National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) have awarded $5 million to an interdisciplinary group of Harvard researchers to launch the Harvard-wide Program on Antibiotic Resistance. Headed by Michael S. Gilmore, Ph.D., (Senior Scientist, Schepens Eye Research Institute and Schepens Professor of Ophthalmology [Department of Microbiology and Molecular Genetics], HMS), the group is uniting Harvard institutions in the fight against methicillin-resistant Staphylococcus aureus (MRSA) and other antibiotic resistant infection. The goal of the project is for the research team with a range of expertise to tackle the problem from different directions, and then to translate those findings into better treatments.
Oct 13, 2009 - 4:00:00 AM
|
Latest Research
Researchers discover mechanism that helps humans see in bright and low light
Oct. 13, 2009 -- Ever wonder how your eyes adjust during a blackout? When we go from light to near total darkness, cells in the retina must quickly adjust. Vision scientists at Washington University School of Medicine in St. Louis have identified an intricate process that allows the human eye to adapt to darkness very quickly. The same process also allows the eye to function in bright light.
Oct 13, 2009 - 4:00:00 AM
|
Latest Research
Major health care challenges persist for D.C. children despite high rates of health insurance coverage, RAND study finds
Despite high rates of health insurance coverage among children in the District of Columbia, children's access to health care is inadequate and poses a significant health problem for the city's young residents, particularly those who are publicly insured, according to a RAND Corporation study issued today.
Oct 8, 2009 - 4:00:00 AM
|
Latest Research
Case Western Reserve awarded $1.57M for corneal infection research
Researchers at Case Western Reserve University School of Medicine have been awarded a $1.57 million renewal grant from the National Eye Institute (NEI) of the National Institutes of Health to continue their study of corneal infections, specifically, bacterial keratitis, associated with contact lens wear. The grant will extend the work initiated last year with the receipt of a $2.4 million, five-year grant from the NEI.
Oct 7, 2009 - 4:00:00 AM
|
Latest Research
K-State scientist receives grant from National Institutes of Health to research cataracts
Research at Kansas State University is investigating the molecular composition of cataracts in hopes of developing a nonsurgical method to prevent or reverse the eye disease.
Jul 14, 2009 - 4:00:00 AM
|
Latest Research
K-State scientist receives grant from National Institutes of Health to research cataracts
Research at Kansas State University is investigating the molecular composition of cataracts in hopes of developing a nonsurgical method to prevent or reverse the eye disease.
Jul 14, 2009 - 4:00:00 AM
|
Latest Research
Queen's University study aims at early diagnosis for ADHD and Parkinson's disease
Eye movement tests developed by Queen's University researchers to aid in understanding childhood brain development and healthy aging may also help in the diagnosis of Attention Deficit Hyperactivity Disorder and detecting the early onset of Parkinson's disease. The project has received close to $1 million in recent funding from the Canadian Institutes of Health Research (CIHR).
Jul 13, 2009 - 4:00:00 AM
|
Latest Research
Queen's University study aims at early diagnosis for ADHD and Parkinson's disease
Eye movement tests developed by Queen's University researchers to aid in understanding childhood brain development and healthy aging may also help in the diagnosis of Attention Deficit Hyperactivity Disorder and detecting the early onset of Parkinson's disease. The project has received close to $1 million in recent funding from the Canadian Institutes of Health Research (CIHR).
Jul 13, 2009 - 4:00:00 AM
|
Latest Research
IU School of Optometry named national vision research center
BLOOMINGTON, Ind. -- A group of scientists working in Indiana University's School of Optometry and the Department of Biology will share more than $2.2 million from the National Institutes of Health to support their ongoing vision research.
Jun 29, 2009 - 4:00:00 AM
|
Latest Research
K-State professor awarded $1.48 million to study LASIK complictions
Gary Conrad, a university distinguished professor at Kansas State University's Division of Biology, has received a four-year grant renewal of $1.48 million from The National Eye Institute of the National Institutes of Health to study the cornea.
May 1, 2009 - 4:00:00 AM
|
Latest Research
Study reports success in treating a rare retinal disorder
Ann Arbor, MI--Patients with a rare, blinding eye disease saw their vision improve after treatment with drugs to suppress their immune systems, according to researchers at the University of Michigan Kellogg Eye Center. Because autoimmune retinopathy (AIR) is difficult to diagnose, the biggest challenge now is to find biologic markers that identify patients who can benefit from treatment.
Apr 14, 2009 - 4:00:00 AM
|
Latest Research
ORNL, UT project could save vision of millions
OAK RIDGE, Tenn., Feb. 17, 2009 -- In the blink of an eye, people at risk of becoming blind can now be screened for eye diseases such as diabetic retinopathy and age-related macular degeneration.
Feb 17, 2009 - 5:00:00 AM
|
Latest Research
Vigorous exercise may help prevent vision loss
Berkeley, CA -- There's another reason to dust off those running shoes. Vigorous exercise may help prevent vision loss, according to a pair of studies from the U.S. Department of Energy's Lawrence Berkeley National Laboratory. The studies tracked approximately 31,000 runners for more than seven years, and found that running reduced the risk of both cataracts and age-related macular degeneration.
Feb 9, 2009 - 5:00:00 AM
|
Latest Research
From outer space to the eye clinic: New cataract early detection technique
A compact fiber-optic probe developed for the space program has now proven valuable for patients in the clinic as the first non-invasive early detection device for cataracts, the leading cause of vision loss worldwide.
Jan 12, 2009 - 5:00:00 AM
|
Latest Research
Research 'A' team to fast track Bionic Eye, Australian consortium announced
Tens of thousands of people with severe vision loss are set to benefit after the announcement today of a landmark partnership of world-leading Australian research institutes.
Nov 12, 2008 - 5:00:00 AM
|
Latest Research
:
Ophthalmology
Sunlight, low anti-oxidant levels likely to damage vision
London - The combination of low antioxidant levels and exposure to sunlight may damage certain kinds of vision. It is also linked with age-related macular degeneration -.
Nov 3, 2008 - 1:27:53 PM
|
Latest Research
:
Ophthalmology
:
Cataract
Kuwaiti surgeon develops new method to treat cataract
Dubai, Oct 18 - A Kuwaiti eye specialist has invented a process by which cataracts can be treated with a rentiscope without going for the complex option of retina transplant.
Oct 18, 2008 - 5:04:42 PM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
Post Menopausal Hormones - reduces risk of macular degeneration
Women who take postmenopausal hormones appear to have a lower risk of developing advanced stages of the eye disease age-related macular degeneration, especially if they had also taken oral contraceptives in the past, according to a report in the April issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Apr 14, 2008 - 1:52:27 PM
|
Latest Research
:
Ophthalmology
:
Retina
New Findings Indicate That Eyes Can Regenerate Damaged Retinas
Washington, March 20 - It might be possible to turn on the eye's own resources to regenerate damaged retinas, without the need for transplanting outside retinal tissue or stem cells, according to a new study.
Mar 20, 2008 - 11:32:50 AM
|
Latest Research
:
Ophthalmology
Coffee drinking protects against an eyelid spasm
People who drink coffee are less likely to develop an involuntary eye spasm called primary late onset blepharospasm, which makes them blink uncontrollably and can leave them effectively "blind", according to a study published online ahead of print in the Journal of Neurology Neurosurgery and Psychiatry.
Jun 21, 2007 - 4:00:00 AM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
Higher fish consumption have a reduced risk of advanced age-related macular degeneration
Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease, according to two reports in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
May 14, 2007 - 8:33:58 PM
|
Latest Research
:
Ophthalmology
Dry Eye Syndrome affects quality of life
As a clinical diagnosis, Dry Eye Syndrome (DES) may not appear to be a major health issue, but in a study published in the March issue of the American Journal of Ophthalmology, researchers found that DES had a significant impact on quality of life.
Mar 10, 2007 - 12:30:16 AM
|
Latest Research
:
Ophthalmology
Choroideremia- fault in the retinal pigment epithelium
Choroideremia is an X chromosome-linked hereditary retinal degenerative disease that leads to blindness in an estimated one in every 100,000 people. This study has found that the transportation process in the photoreceptors is perfectly normal, but the neighboring RPE is defective, which is why the photoreceptors die.
Mar 7, 2007 - 6:19:25 PM
|
Latest Research
:
Ophthalmology
Glaucoma patients at significantly higher risk for falls, motor vehicle accidents
Persons affected by glaucoma are over three times more likely to have been involved in falls and motor vehicle accidents than persons of the same age without the condition, say researchers from Dalhousie University in Canada. Their findings are published in the March 2007 issue of Investigative Ophthalmology & Visual Science.
Feb 28, 2007 - 10:20:23 AM
|
Latest Research
:
Ophthalmology
:
Retina
Genetics key factor in retinopathy of prematurity (ROP)
Genetics play a major role in predisposing infants to retinopathy of prematurity (ROP), a disease prevalent in premature infants that disrupts normal blood vessel development of the retina and can lead to blindness, researchers at Yale School of Medicine report in the November issue of Pediatrics.
Nov 24, 2006 - 9:24:18 AM
|
Latest Research
:
Ophthalmology
Serious eye infection linked with contact lens solution
In the final analysis, case patients were more than 20 times more likely than controls to report using a specific contact lens solution, ReNu with MoistureLoc.
Nov 24, 2006 - 1:00:00 AM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
HTRA1 gene linked to aggressive 'wet' age-related macular degeneration
A gene variant that increases the risk of developing the aggressive "wet" form of age-related macular degeneration (AMD), the most common cause of blindness in people over age 50, is reported in two recent articles in Science by researchers at Yale School of Medicine.
Nov 23, 2006 - 9:13:40 PM
|
Latest Research
:
Ophthalmology
:
Retina
Master Proteins Dictate Retinal Differentiation Timetable
The embryonic construction of the vertebrate retina is a highly ordered affair. Following a precise timetable, six different specialized cell types emerge from a mass of identical, proliferating cells. The process of retinal cell differentiation, when so-called progenitor cells stop dividing and choose among the six fates, depends primarily on homeobox genes, major regulators of embryonic patterning. How these genes control the timing of retinal cell differentiation has remained an open question—until now.
Aug 16, 2006 - 8:41:00 AM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
Yellow plant pigments lutein and zeaxanthin reduce risk of age-related macular degeneration
Women younger than age 75 years who eat diets rich in the yellow plant pigments lutein and zeaxanthin may have a reduced risk of developing the eye disease age-related macular degeneration, according to a report in the August issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Age-related macular degeneration (AMD) occurs when the macula, the area at the back of the retina that produces the sharpest vision, deteriorates over time. The condition is the leading cause of blindness in aging Americans, according to background information in the article. There is no cure for AMD and limited treatment options are available to slow its progression, so research on preventive measures is essential. Previous studies have suggested a potential link between AMD and lutein and zeaxanthin, plant pigments known as carotenoids and found in leafy green vegetables, corn, egg yolks, squash, broccoli and peas. These compounds may reduce the risk of AMD by absorbing blue light that could damage the macula, by preventing free radicals from damaging eye cells and by strengthening eye cell membranes.
Aug 15, 2006 - 11:41:00 AM
|
Latest Research
:
Ophthalmology
:
Retina
Objective way to diagnose diseases of colour perception
Pictures of brain waves that reveal our ability to see colour could provide a new objective way to diagnose and monitor diseases that affect human colour perception. The research finding by a Universiy of New South Wales PhD student, Ms Mei Ying Boon, has earned her a nomination in this year's Fresh Science Awards.
Aug 10, 2006 - 2:59:00 PM
|
Latest Research
:
Ophthalmology
Onchocerciasis treatment reduces prevalence and intensity by 38%
Onchocerciasis, river blindness or craw craw is an endemic disease in Bioko Island, Equatorial Guinea. This pathology causes a weakening in affected individuals, most of them within the labour force population, making this disease one of the limiting factors for the economic development of the island.
Jul 31, 2006 - 11:45:00 AM
|
Latest Research
:
Ophthalmology
:
Retina
Antioxidants may slow retinal degeneration
Scientists at Johns Hopkins have successfully blocked the advance of retinal degeneration in mice with a form of retinitis pigmentosa (RP) by treating them with vitamin E, alpha-lipoic acid and other antioxidant chemicals.
Jul 20, 2006 - 8:22:00 PM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
Hormone Therapy Does Not Affect Age-Related Vision Loss
Postmenopausal hormone therapy does not appear to increase or decrease the overall risk of AMD among women, although combination hormones may slightly reduce the chances of developing certain risk factors or types of the condition, according to a report in the July issue of the Archives of Ophthalmology, one of the JAMA/Archives journals.
Jul 12, 2006 - 5:59:00 AM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
Eating Fish Protects Against Macular Degeneration
In a study, Brian Chua, B.Sc., M.B.B.S., M.P.H., Westmead Millennium Institute and Vision Co-operative Research Centre, Syndney, Australia, and colleagues examined the association between dietary fat intake and AMD risk in 2,895 Australians age 49 years or older, beginning in 1992-1994. At the beginning of the study and again five years later, participants had a comprehensive eye exam that included photographs of the retina. They also filled out a questionnaire with data about food types and portion sizes consumed, including specific information about margarines, butters, oils and supplements.
Jul 12, 2006 - 5:53:00 AM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
Research Highlights Risk Factors For Age-Related Vision Loss
Eating fish frequently may be associated with decreased chances of developing age-related macular degeneration, while smoking nearly doubles the risk for this common cause of vision loss and hormone therapy appears to have no effect, according to three articles in the July issue of the Archives of Ophthalmology, one of the JAMA/Archives journals.
Jul 12, 2006 - 5:50:00 AM
|
Latest Research
:
Ophthalmology
How Thalamic Neurons Grab Your Attention
Certain salient features in a visual scene grab our attention, such as a tiger emerging from a field of tall grass, after which we may spend more time taking in the details. Both ways of experiencing the world are automatic, and the neurons that make up the brain's visual system switch between these two modes continuously. But the exact neurons and mechanisms responsible are still a mystery to neuroscientists.
Jul 12, 2006 - 5:27:00 AM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
FDA approves ranibizumab for the treatment of wet age-related macular degeneration
The Food and Drug Administration (FDA) today approved Lucentis (ranibizumab injection) for the treatment of patients with neovascular (wet) age-related macular degeneration (AMD). Lucentis is the first treatment which, when dosed monthly, can maintain the vision of more than 90 percent of patients with this type of AMD.
Jul 6, 2006 - 2:23:00 AM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
High Body Mass Index Increase the Genetic Risk of AMD
Current cigarette smoking was associated with a fivefold increased risk and high BMI (30 or higher) was associated with a twofold higher risk of AMD. The homozygous risk genotype (CC) plus smoking conferred a tenfold higher risk of AMD, compared with non-smokers with the non-risk (TT) genotype, while the risk genotype plus higher BMI increased risk of AMD almost sixfold. Gene plus environment risk scores provided an area under the receiver operating characteristic (ROC) curve of 0.70-0.75. The attributable risks for the combination of genes and environment were 69% to 73%.
Jul 1, 2006 - 5:41:00 PM
|
Latest Research
:
Ophthalmology
:
Retina
:
ARMD
Ranibizumab Approved for Wet Age-Related Macular Degeneration
The Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) for the treatment of patients with neovascular (wet) age-related macular degeneration (AMD). Lucentis is the first treatment which, when dosed monthly, can maintain the vision of more than 90 percent of patients with this type of AMD. Lucentis is a new molecular entity (NME), meaning it contains an active substance that has never before been approved for marketing in any form in the United States. Lucentis will be the first FDA--approved product to provide prescription information in the new format for prescription drug package inserts, to provide professionals and consumers clear and concise prescription information.
Jul 1, 2006 - 4:41:00 PM
|
|
|
|
|
